APOE Genotype, Triglycerides, and Brain Blood Flow Study

This study is looking at how a high-fat drink, specifically 100 ml of heavy cream, affects blood flow in the brain of older adults. Researchers want to understand if carrying a specific gene called APOE E4, which is linked to Alzheimer's disease, changes how your brain responds to fat. You can join if you are 55 or older, and the study aims to include an equal number of APOE E4 carriers and non-carriers, as well as men and post-menopausal women. The main goal is to see the difference in global cerebral blood flow (blood flow in the brain) two hours after drinking the heavy cream. The study is currently unclear on its recruitment status and plans to enroll 90 participants.

Study design
This interventional study plans to enroll 90 older adults, with an equal number of APOE E4 carriers and non-carriers.
What's involved
You will have a screening visit involving a blood draw, an oral triglyceride tolerance test, and a DEXA scan. The study visit includes an MRI to measure brain blood flow before and 2 hours after drinking heavy cream, 6 blood draws, and a 30-minute cognitive test.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint is measured at 2 hours after the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04692441

Apolipoprotein E (APOE) Genotype Effects on Triglycerides and Blood Flow in the Human Brain

Active, Not Recruiting
NAAges 55+InterventionalBasic science
University of Washington
~90 participants
Updated 2026-07-08 on ClinicalTrials.gov
What's tested:Heavy Cream

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Difference in global cerebral blood flow between baseline and 2 hours post lipid ingestion (Change CBF)
Measured over 2 Hour Change
Alzheimer Disease
Dementia
1 sites across 1 states
Washington1
  • Angela J Hanson, MD · PRINCIPAL_INVESTIGATOR · University of Washington

This trial hasn't published a contact. View it on ClinicalTrials.gov

  • Difference in global cerebral blood flow between baseline and 2 hours post lipid ingestion (Change CBF)2 Hour Change

    Change in global cerebral blood flow (CBF) in ml/100g/min, calculated as the subtracted difference between the pre- and the post-ASL flow in response to the intervention.